Skip to main content
IART
NASDAQ Industrial Applications And Services

Integra LifeSciences Extends $150M Accounts Receivable Securitization Facility to 2029

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$11.03
Mkt Cap
$859.647M
52W Low
$8.7
52W High
$17.54
52W Position info
27% above low
Off High info
37% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

IART sits 27% above its 52-week low of $8.7.

Summary

Integra LifeSciences Holdings Corporation has extended its $150 million accounts receivable securitization facility until April 10, 2029, enhancing its liquidity and funding for ongoing business needs.


Key Events · Financing and Capital Events · IART

  • Facility Extension Confirmed

    Integra LifeSciences formally extended its $150 million accounts receivable securitization facility to April 10, 2029, an extension of three years.

  • Enhanced Liquidity

    The extension provides crucial additional liquidity and funding for the company's ongoing business operations.

  • Addresses Financial Needs

    This agreement is particularly important following the company's reported $516.5 million net loss and goodwill impairment in its 2025 annual report, providing essential financial stability.


Analysis · IART · Industrial Applications And Services

This extension of a substantial $150 million accounts receivable securitization facility is a critical positive development for Integra LifeSciences. Given the company's recent disclosure of a significant net loss and goodwill impairment in its 2025 10-K, securing this liquidity for an additional three years (until April 2029) provides essential financial stability and operational runway. It demonstrates continued access to capital, which is vital for a company navigating financial challenges and supporting its ongoing business needs.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IART was trading at $11.03 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $859.6M. The 52-week trading range was $8.70 to $17.54. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IART - Latest Insights

IART
Oct 21, 2026, 1:00 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $12.43
Real-time Price: $14.45 info
Change: +$2.02 (+16%) info
Market Cap: $1.088B info
IART
Oct 21, 2026, 6:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.25
Real-time Price: $14.45 info
Change: +$1.20 (+9%) info
Market Cap: $1.088B info
IART
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $13.25
Real-time Price: $14.45 info
Change: +$1.20 (+9%) info
Market Cap: $1.088B info
IART
Oct 19, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.45
Real-time Price: $14.45 info
Change: +$1.00 (+7%) info
Market Cap: $1.088B info
IART
Oct 09, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.44
Real-time Price: $14.45 info
Change: +$1.01 (+8%) info
Market Cap: $1.088B info